ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

Institute Of Medicine: External Experts Should Vet Large Projects, Report Says.

June 20, 2003

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998